Seth Berkley

But ultimately, we were able to get very high coverage, which is, I think, a big positive of this effort.

That's for the malaria vaccine particularly, but yeah.

Well, I certainly, I can frame it, but I certainly can't make it make sense because it makes no sense.

Yeah.

Just to say that, you know, the progress on vaccines has been extraordinary.

So, you know, we went from having six basic vaccines to having vaccines against the largest killers of children, diarrhea and pneumonia.

We began to have vaccines against common cancers.

So we rolled out in China, for example, a vaccine against liver cancer.

They had 350,000 cases a year of this disease.

And, you know, you can't do liver transplants in those days, you know, for that population.

So terrible death rates from hepatitis B, where there was transmission and

And cervical cancer, again, we're in the process of rolling that out worldwide to get women, because this is in many countries the largest cancer killer of women, and now parasitic diseases.

And to your point, we're beginning to now have vaccines against primer tumor antigens.

And so, you know, we're going to have, you know, immunotherapy for cancer.

cancers and prevention for cancers and prevention for other infectious diseases that antecede.

And we'll have vaccines, I predict, also for chronic diseases and immune diseases, et cetera.

So a lot of stuff is happening.

Now, meanwhile...

We have two different problems.

We have vaccine hesitancy, and that's existed from the beginning.